Skip to content

US · AVAH · MEDICAL - CARE FACILITIES

Aveanna Healthcare Holdings Inc. (AVAH) intrinsic value and stock valuation

$11.01as of 2026-11-21 · Mkt cap 2.07B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Aveanna Healthcare Holdings Inc. DCF and intrinsic value

InvestorsCraft values AVAH with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AVAH’s statements →

Aveanna Healthcare Holdings Inc. Graham Number

Graham Number: $4.88d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Atlanta, GA 30339 aveanna.com

How the business is doing

Fiscal 2018–2026, USD

Revenue
$2.43B+10.2% 5y CAGRd
20182026
Net income
$225M
20182026
Free cash flow
$114.8M
20182026
Total equity
$194.5M-6.4% 5y CAGRd
20182026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2026, USD
20262024202320222021
Revenue$2.43B$2.02B$1.9B$1.79B$1.68B
Operating income$265.4M$139.8M$8.07M-$-642.28M-$-36.11M
Net income$225M-$-10.93M-$-134.52M-$-662.03M-$-117.04M
EPSd$1.05M-$-56.66K-$-708.15K-$-3.57M-$-633.57K
Operating cash flow$122.2M$32.6M$22.7M-$-48.4M—
Capital expenditure-$-7.45M-$-6.32M-$-6.12M-$-12.01M—
Free cash flow$114.8M$26.3M$16.6M-$-60.41M—
Total assets$2.03B$1.66B$1.61B$1.71B—
Total debt$1.51B$1.5B$1.5B$1.36B—
Net debt$1.32B$1.42B$1.46B$1.34B—
Total equity$194.5M-$-122.09M-$-127.44M-$-4.17M—
Cash and short-term investments$193.3M$84.3M$43.9M$19.2M—
Income statement
20262024202320222021
Revenue$2.43B$2.02B$1.9B$1.79B$1.68B
Cost of revenue$1.63B$1.39B$1.3B$1.23B$1.14B
Gross profit$805.2M$635.5M$595.4M$553.2M$542.4M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$526.7M$470.5M$464.7M$484M$419.6M
Other expenses$13M$25.3M$122.6M$711.6M$158.9M
Operating expenses$539.8M$495.8M$587.4M$1.2B$578.5M
Cost and expenses$2.17B$1.88B$1.89B$2.43B$1.71B
Interest income$2.83M$500K$330K$680K$250K
Interest expense$140.1M$156.6M$153.3M$107.7M$68.9M
Depreciation and amortization$23.8M$31.2M$30.1M$38.8M$35.4M
Ebitda$274.6M$187.4M$39.2M-$-525.06M-$-17.95M
Operating income$265.4M$139.8M$8.07M-$-642.28M-$-36.11M
Total other income/expenses, net-$-158.43M-$-134.72M-$-147.07M-$-21.54M-$-77.47M
Income before tax$107M$5.07M-$-139M-$-663.81M-$-113.58M
Income tax expense-$-118.09M$16M-$-4.47M-$-1.78M$3.47M
Net income$225M-$-10.93M-$-134.52M-$-662.03M-$-117.04M
Weighted average shares outstanding$203.5M$192.9M$190M$185.6M$184.7M
Weighted average diluted shares outstanding$215M$192.9M$190M$185.6M$184.7M
Balance sheet
20262024202320222020
Cash and short-term investments$193.3M$84.3M$43.9M$19.2M$137.3M
Net receivables$313.4M$277.7M$245.8M$225.6M$180.9M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$560.2M$392.7M$314.9M$269.8M$340.6M
Property, plant and equipment, net$55.7M$58.7M$70.1M$77.4M$78.9M
Goodwill and intangible assets$1.21B$1.14B$1.15B$1.26B$1.39B
Long-term investments$37.5M$60.6M$74.8M$0.00$0.00
Total non-current assets$1.47B$1.27B$1.3B$1.44B$1.5B
Total assets$2.03B$1.66B$1.61B$1.71B$1.84B
Accounts payable$32M$36.4M$30.1M$44.6M$56.7M
Short-term debt$200.4M$198.6M$183M$28.5M$24.7M
Deferred revenue$0.00$0.00$0.00$0.00$29.4M
Total current liabilities$424.5M$402.2M$354.8M$326.5M$260.4M
Long-term debt$1.31B$1.3B$1.32B$1.33B$1.2B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.41B$1.38B$1.39B$1.39B$1.32B
Capital lease obligations$43.4M$47.2M$54.7M$58.9M$52.1M
Total liabilities$1.83B$1.79B$1.74B$1.72B$1.58B
Common stock$2.11M$1.93M$1.91M$1.89M$1.42M
Retained earnings-$-1.16B-$-1.38B-$-1.37B-$-1.24B-$-457.63M
Accumulated other comprehensive income (loss)$0.00$1.46M$2.13M$0.00$0.00
Total equity$194.5M-$-122.09M-$-127.44M-$-4.17M$267.2M
Total investments$37.5M$60.6M$74.8M$0.00$0.00
Total debt$1.51B$1.5B$1.5B$1.36B$1.23B
Net debt$1.32B$1.42B$1.46B$1.34B$1.09B
Cash flow statement
20262024202320222020
Net income$225M-$-10.93M-$-134.52M-$-662.03M-$-57.05M
Depreciation and amortization$28.2M$31.2M$30.1M$38.8M$30.2M
Stock-based compensation$0.00$17.5M$13.2M$15.9M$3.27M
Change in working capital-$-52.66M-$-29.97M-$-23.4M-$-42.22M$56.5M
Accounts receivable-$-30.22M-$-28.64M-$-15.32M-$-3.23M$8.56M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-6.23M$6.45M-$-13.92M-$-3.92M-$-6.81M
Net cash provided by operating activities$122.2M$32.6M$22.7M-$-48.4M$116.6M
Investments in property, plant and equipment-$-7.45M-$-6.32M-$-6.12M-$-12.01M-$-15.24M
Acquisitions, net-$-14.85M$0.00$0.00-$-1.55M-$-178.31M
Net cash used for investing activities-$-22.3M-$-6.32M-$-8.79M-$-25.29M-$-193.54M
Common stock issued$6.52M$3.09M$940K$4.01M$50M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$9.03M$14M$10.9M$62.4M$210.9M
Net change in cash$109M$40.4M$24.7M-$-11.27M$134M
Cash at end of period$193.3M$84.3M$43.9M$19.2M$137.3M
Operating cash flow$122.2M$32.6M$22.7M-$-48.4M$116.6M
Capital expenditure-$-7.45M-$-6.32M-$-6.12M-$-12.01M-$-15.24M
Free cash flow$114.8M$26.3M$16.6M-$-60.41M$101.4M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Aveanna Healthcare Holdings Inc.

        Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.

        CEO
        Jeffrey S. Shaner
        Employees
        35.5K
        Beta
        1.89

        Explore

        Frequently asked questions

        What is the intrinsic value of Aveanna Healthcare Holdings Inc. (AVAH)?

        InvestorsCraft does not currently publish an intrinsic value for AVAH. How the IC value is calculated.

        Is AVAH undervalued?

        InvestorsCraft does not publish an undervaluation signal for AVAH at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.